Last reviewed · How we verify
intravenous morphine titration
At a glance
| Generic name | intravenous morphine titration |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department (PHASE3)
- Fentanyl Versus Hydromorphone in Patients on Mechanical Ventilation (PHASE2)
- IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration (PHASE3)
- Effect of the Early Ultrasound-guided Femoral Nerve Block Performed by Emergency Physicians on Pre-operative Opioids Usage in Patients With Proximal Femoral Fractures (NA)
- Titration of Intravenous Hydromorphone (PHASE4)
- Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS) (PHASE2)
- PEF-Block & Ribs Fractures (NA)
- Compare Continuous Gastrocnemius Plane Block With Intravenous Analgesia After Foot and Ankle Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: